Skip to main content
SpringerLink
Log in

Diagnostic et évaluation clinique des douleurs neuropathiques : quel est l’intérêt des nouveaux outils ?

Screening and assessment of neuropathic pain: what is the relevance of pain quality measures?

  • Mise Au Point / Update
  • Published:
Douleur et Analgésie

Résumé

Les douleurs neuropathiques (DN) peuvent être secondaires à une grande variété de lésions nerveuses périphériques ou centrales. Malgré cette diversité, ces douleurs présentent en commun un certain nombre de caractéristiques cliniques permettant de les différencier des douleurs d’autres origines. Cette revue fait le point sur les avancées cliniques récentes concernant le dépistage et l’évaluation clinique des DN. Ces avancées concernent le développement d’outils de dépistage de ces douleurs ayant permis notamment la réalisation récente d’études épidémiologiques en population générale, ainsi que le développement de questionnaires d’évaluation, dont un des principaux objectifs est de faciliter la prédiction des profils symptomatiques de répondeurs aux traitements des DN.

Abstract

Neuropathic pain is caused by a large variety of peripheral or central neuropathic lesions. Despite such heterogeneity, neuropathic pain syndromes share clinical characteristics that may help differentiate them from other forms of chronic pain states. This review focuses on pain quality diagnostic and assessment tools specifically developed for neuropathic pain. These clinical tools have been particularly helpful to conduct epidemiological studies of neuropathic pain and should contribute to enhance the prediction of responder profiles to treatments in clinical trials of neuropathic pain.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Références

  1. Recommandations de la HAS sur le diagnostic des lésions nerveuses périphériques (2007).

  2. Attal N, Fermanian C, Fermanian J, et al (2008) Neuropathic pain: are there distinct subtypes depending on the aetiology or anatomical lesion? Pain 138: 343–53

    Article  CAS  PubMed  Google Scholar 

  3. Backonja MM, Krause SJ (2003) Neuropathic Pain Questionnaire — short form. Clin J Pain 19: 315–6

    Article  PubMed  Google Scholar 

  4. Baron R, Tölle TR, Gockel U, et al (2009) A cross-sectional cohort survey in 2,100 patients with painful diabetic neuropathy and postherpetic neuralgia: Differences in demographic data and sensory symptoms. Pain 146(1-2): 34–40

    Article  PubMed  Google Scholar 

  5. Bennett MI (2001) The LANSS Pain Scale: the Leeds Assessment of Neuropathic Symptoms and Signs. Pain 92(1–2): 147–57

    Article  CAS  PubMed  Google Scholar 

  6. Bennett MI, Attal N, Backonja MM, et al (2007) Using screening tools to identify neuropathic pain. Pain 127: 199–203

    Article  PubMed  Google Scholar 

  7. Bennett MI, Bouhassira D (2007) Epidemiology of neuropathic pain; can we use the screening tools? Pain 132: 12–3

    Article  PubMed  Google Scholar 

  8. Bennett MI, Smith BH, Torrance N, Potter J (2005) The S-LANSS score for identifying pain of predominantly neuropathic origin: validation for use in clinical and postal research. J Pain 6(3): 149–58

    Article  PubMed  Google Scholar 

  9. Bouhassira D, Attal N (2009) All in one: is it possible to assess all dimensions of any pain with a simple questionnaire? Pain 144: 7–8

    Article  PubMed  Google Scholar 

  10. Bouhassira D, Attal N, Alchaar H, et al (2005) Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain 114: 29–36

    Article  PubMed  Google Scholar 

  11. Bouhassira D, Attal N, Fermanian J, et al (2004) Development and validation of the Neuropathic Pain Symptom Inventory. Pain 108: 248–57

    Article  PubMed  Google Scholar 

  12. Bouhassira D, Lantéri-Minet M, Attal N, et al (2008) Prevalence of chronic pain with neuropathic characteristics in the general population. Pain 136:380–7

    Article  PubMed  Google Scholar 

  13. Boureau F, Doubrère JF, Luu M (1990) Study of verbal description in neuropathic pain. Pain 42: 145–52

    Article  CAS  PubMed  Google Scholar 

  14. Boureau F, Luu M, Doubrère JF (1992) Comparative study of the validity of four French McGill Pain Questionnaire (MPQ) versions. Pain 50: 59–65

    Article  CAS  PubMed  Google Scholar 

  15. Boureau F, Luu M, Doubrère JF, Gay C (1984) Élaboration d’un questionnaire d’autoévaluation de la douleur par liste de qualificatifs. Comparaison avec le McGill Questionnaire de Melzack. Thérapie 39: 119–29

    CAS  PubMed  Google Scholar 

  16. Cruccu G, Sommer C, Attal N, et al (2010) EFNS guidelines on neuropathic pain assessment. 2009 revision. E J Neurol (in press)

  17. Dubuisson D, Melzack R (1976) Classification of clinical pain descriptions by multiple group discriminant analysis. Exp Neurol 51: 480–7

    Article  CAS  PubMed  Google Scholar 

  18. Dworkin RH, Turk DC, Revicki DA, et al (2009) Development and initial validation of an expanded and revised version of the Short-form McGill Pain Questionnaire (SFMPQ-2). Pain 144: 35–42

    Article  PubMed  Google Scholar 

  19. Freynhagen R, Baron R, Gockel U, Tolle T (2006) PainDetect: a new screening questionnaire to detect neuropathic components in patients with back pain. Curr Med Res Opin 22: 1911–20

    Article  PubMed  Google Scholar 

  20. Galer BS, Jensen MP (1997) Development and preliminary validation of a pain measure specific to neuropathic pain: the Neuropathic Pain Scale. Neurology 48: 332–8

    CAS  PubMed  Google Scholar 

  21. Galer BS, Jensen MP, Ma T, et al (2002) The lidocaine patch 5% effectively treats all neuropathic pain qualities: results of a randomised, double blind, vehicle-controlled, 3-week efficacy study with use of the Neuropathic Pain Scale. Clin J Pain 18: 297–301

    Article  PubMed  Google Scholar 

  22. Gilron I, Attal N, Bouhassira B, Dworkin RH (2010) Assessment of Neuropathic Pain (NP). In: Handbook of Pain Assessment, 3rd edition, Melzack R, Turk D (eds) Guilford Press (in press)

  23. Gilron I, Bailey JM, Tu D, et al (2005) Morphine, gabapentin or their combination for neuropathic pain. N Engl J Med 352: 1324–34

    Article  CAS  PubMed  Google Scholar 

  24. Hansson P (2003) Difficulties in stratifying neuropathic pain by mechanisms. Eur J Pain 7: 353–7

    Article  PubMed  Google Scholar 

  25. Hatem S, Attal N, Gautron M, et al (2009) Relationship between structural lesions of spinal cord sensory tracts and neuropathic pain in syringomyelia patients. Abstract, EFIC, Lisbonne

    Google Scholar 

  26. Jensen MP (2005) Using pain quality assessment measures for selecting analgesic agents. Clin J Pain 22: S9–S13

    Google Scholar 

  27. Jensen MP, Friedman M, Bonzo D, Richards P (2006) The validity of the Neuropathic Pain Scale for assessing diabetic neuropathic pain in a clinical trial. Clin J Pain 22: 97–103

    Article  PubMed  Google Scholar 

  28. Jensen MP, Gammaitoni AR, Olaleye DO, et al (2006) The pain quality assessment scale: assessment of pain quality in carpal tunnel syndrome. J Pain 7: 823–32

    Article  PubMed  Google Scholar 

  29. Jensen TS, Baron R (2003) Translation of symptoms and signs into mechanisms in neuropathic pain. Pain 102: 1–8

    Article  PubMed  Google Scholar 

  30. Krause SJ, Backonja MM (2003) Development of a neuropathic pain questionnaire. Clin J Pain 19: 306–14

    Article  PubMed  Google Scholar 

  31. Martinez V, Attal N, Bouhassira D, et al (2010) Les douleurs neuropathiques chroniques: diagnostic, évaluation, traitement en médecine ambulatoire. Recommandation pour la pratique clinique de la Société française d’étude et de traitement de la douleur. Doul Analg 23: 51–66

    Article  Google Scholar 

  32. Martinez V, Fletcher D, Martin F, et al (2010) Small fiber impairment predicts neuropathic pain in Guillain Barre syndrome. Pain (in press)

  33. Melzack R (1975) The Mac Gill Pain Questionnaire: Major properties and scoring methods. Pain 1: 275–99

    Google Scholar 

  34. Melzack R (1987) The Short-form McGill Pain Questionnaire. Pain 30: 191–7

    Article  CAS  PubMed  Google Scholar 

  35. Merskey H, Bogduk N (1994) Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms. IASP Press, Seattle

    Google Scholar 

  36. Perez C, Galvez R, Huelbes S, et al (2007) Validity and reliability of the Spanish version of the DN4 (douleur neuropathique quatre questions) questionnaire for differential diagnosis of pain syndromes associated to a neuropathic or somatic component. Health Qual Life Outcomes 5: 66

    Article  PubMed  Google Scholar 

  37. Portenoy R (2006) Development and testing of a neuropathic pain screening questionnaire: ID Pain. Curr Med Res Opin 22: 1555–65

    Article  PubMed  Google Scholar 

  38. Ranoux D, Attal N, Morain F, Bouhassira D (2008) Botulinum toxin A induces direct analgesic effects in neuropathic pain: a double blind placebo controlled study. Neurol 64: 274–83

    Google Scholar 

  39. Scholz J, Mannion RJ, Hord DE, et al (2009) A novel tool for the assessment of pain: validation in low back pain. PLoS Med 6(4): e1000047

    Article  PubMed  Google Scholar 

  40. Simpson DM, McArthur JC, Olney R, et al (2003) Lamotrigine for HIV-associated painful sensory neuropathies: a placebo-controlled trial. Neurology 60: 1508–14

    CAS  PubMed  Google Scholar 

  41. Torrance N, Smith BH, Bennett MI, Lee AJ (2006) The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey. J Pain 7(4): 281–9

    Article  PubMed  Google Scholar 

  42. Treede RD, Jensen TS, Campbell JN, et al (2008) Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology 70: 1630–5

    Article  CAS  PubMed  Google Scholar 

  43. Truini A, Padua L, Biasiotta A, et al (2009) Differential involvement of A-delta and A-beta fibres in neuropathic pain related to carpal tunnel syndrome. Pain 145(1–2): 105–9

    Article  CAS  PubMed  Google Scholar 

  44. Van Acker K, Bouhassira D, De Bacquer D, et al (2009) Prevalence and impact on quality of life of peripheral neuropathy with or without neuropathic pain in type 1 and type 2 diabetic patients attending hospital outpatients clinics. Diabetes Metab 35(3): 206–13

    Article  PubMed  Google Scholar 

  45. Victor TW, Jensen MP, Gammaitoni AR, et al (2008) The dimensions of pain quality: factor analysis of the Pain Quality Assessment Scale. Clin J Pain 24: 550–5

    Article  PubMed  Google Scholar 

  46. Vranken J, Hollmann MW, van der Vegt MH, et al (2010) Duloxetine in patients with central neuropathic pain: a randomised, double blind, placebo-controlled trial of a flexible-dose regimen. Pain (in press)

  47. Yuan RY, Sheu JJ, Yu JM, et al (2009) Botulinum toxin for diabetic neuropathic pain: a randomised double blind crossover trial. Neurology 72(17): 1473–8

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Inserm, U987, centre d’évaluation et de traitement de la douleur, hôpital Ambroise-Paré, 9, avenue Charles-de-Gaulle, F-92100, Boulogne-Billancourt, France

    N. Attal

Authors
  1. N. Attal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to N. Attal.

About this article

Cite this article

Attal, N. Diagnostic et évaluation clinique des douleurs neuropathiques : quel est l’intérêt des nouveaux outils ?. Douleur analg 23, 70–77 (2010). https://doi.org/10.1007/s11724-010-0191-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11724-010-0191-y

Mots clés

Keywords

Search

Navigation